Key role of acetyl-CoA in cytoplasm of nerve terminals in disturbances of acetylcholine metabolism in brain

Folia Neuropathologica

Volumn 35, Issue 4, 1997, Pages 241-243

  Szutowicz, Andrzej ^a,b   Tomaszewicz, Maria ^a   Bielarczyk, Hanna ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b School of Medicine   (Poland)

Author keywords

Acetylcholine metabolism; Nerve terminals

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYL COENZYME A; ACETYLCHOLINE; ALUMINUM; ENZYME INHIBITOR; PYRUVIC ACID;

ANIMAL; BRAIN; BRAIN DISEASE; CHOLINERGIC NERVE; CYTOPLASM; DIABETES MELLITUS; DRUG EFFECT; ENERGY METABOLISM; HUMAN; METABOLISM; PHYSIOLOGY; RAT; REVIEW; SYNAPTOSOME;

3-HYDROXYBUTYRIC ACID; ACETYL COENZYME A; ACETYLCHOLINE; ALUMINUM; ANIMALS; BRAIN; BRAIN DISEASES; CHOLINERGIC FIBERS; CYTOPLASM; DIABETES MELLITUS; ENERGY METABOLISM; ENZYME INHIBITORS; HUMANS; PYRUVIC ACID; RATS; SYNAPTOSOMES;

EID: 0031292008     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Benson DF: Alternations in glucose metabolism in Alzheimer's disease. In: Banbury report 15: biological aspects of Alzheimer's disease. Cold Spring Harbor Laboratory, 1983, PP 309-316.
2. Bielarczyk H, Szutowicz A: Evidence for the regulatory function of synaptoplasmic acetyl-CoA in acetylcholine synthesis in nerve endings. Biochem J, 1989, 262, 377-380.
3. Bielarczyk H, Tomaszewicz M, Szutowicz A: Effect of aliminum on acetyl-CoA and acetylcholine metabolism in nerve terminals. J Neurochem, 1997a, in press.
4. Bielarczyk H, Tomaszewicz M, Jankowska A, Kisielewski Y, Szutowicz A: Compartmentation of acetyl-CoA and acetylcholine metabolism in pyrithiamine encephalopathy. In: Neurochemistry, Cellular, Molecular and Clinical Aspects, AW Teelken, J Korf (eds). Plenum Publishing Co, New York 1997b, pp 737-741.
5. Bierer LM, Haroutuanian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanoff P: Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem, 1995, 64, 749-760.
6. Butterworth RF: Pyruvate dehydrogenase deficiency disorders. In: Cerebral Energy Metabolism and Metabolic Encephalopathy. DW McCandless (ed). Plenum Press, New York, 1985, pp 121-141.
7. Dawson VL, Dawson TM: Nitric oxide in neuronal degeneration. Proc Soc Exp Biol Med, 1996, 211, 33-40.
8. Dodd PR, Scott HL, Westphalen RI: Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem Int, 1994, 25, 203-219.
9. Durkin TP, Messier C, DeBoer P, Westerink BHC: Glucose injections increase scopolamine-induced acetylcholine outflow from the hippocampus: an in vivo microdialysis study in the rat. In: Monitoring Molecules in Neurosciences, H Rollemo, BHC Westerink, WJ Drijfhout (eds). University Centre Pharmacy, Groningen, 1991, pp 300-301.
10. Gibson GE, Barclay L, Blass JP: The role of the cholinergic system in thiamin deficiency. Ann New York Acad Sci, 1982, 387, 382-403.
11. Kalaria RN, Harik SI: Reduced glucose transporter at blood-brain barrier and cerebral cortex in Alzheimer's disease. J Neurochem, 1989, 53, 1083-1088.
12. Meiri H, Banin E, Roll M, Rouseau A: Toxic effects of aluminum on nerve cells and synaptic transmission. Prog Neurobiol, 1993, 40, 89-121.
13. Perry EK: The cholinergic hypothesis - ten years on. Brit Med Bull, 1986, 42, 63-69.
14. 2+ ions and the output of acetylcoenzyme A from brain mitochondria. Gen Physiol Biophys, 1983, 2, 27-37.
15. Ričny J, Tuček S, Novakova J: Acetylcarnitine, carnitine and glucose diminish the effect of muscarinic antagonist quiniclidynyl benzilate on striatal acetylcholine content. Brain Res, 1992, 576, 215-219.
16. Szutowicz A, Bielarczyk H: Relationship bewteen pyruvate oxidation, acetyl-CoA compartmentalization and acetylcholine synthesis in nerve terminals. In: Biochemistry and Physiology of Thamin Diphosphate Enzymes. H Bisswanger, J Ulrich (eds), VCH Weinheim, 1991, pp 367-374.
17. Szutowicz A, Bielarczyk H, Skulimowska H: Effect of dichloroacetate on acetyl-CoA content and acetylcholine synthesis in rat brain synaptosomes. Neurochem Res, 1994a, 19, 1107-1112.
18. Szutowicz A, Bielarczyk H, Tomaszewicz M: Metabolism of acetyl-CoA and cholinergic neuropathies. In: Neurochemistry, Cellular, Molecular and Clinical Aspects, AW Teelken, J Korf (eds). Plenum Publishing Co, New York, 1997, pp 821-827.
19. Szutowicz A, Łysiak W, Angielski S: The effect of (-) hydroxycitrate on pyruvate metabolism in rat brain synaptosomes. J Neurochem, 1977, 29, 375-378.
20. Szutowicz A, Tomaszewicz M, Bielarczyk H: Disturbances of acetyl-CoA, energy and acetylcholine metabolism in some encephalopathies. Acta Neurobiol Exp, 1996, 56, 232-339.
21. Szutowicz A, Tomaszewicz M, Jankowska A, Kisielewski Y: Acetylcholine synthesis in nerve terminals of diabetic rats. Neuroreport, 1994b, 5, 2421-2424.
22. Takahashi A, Ishimaru H, Ikarashi E, Maruyama Y: Hypothalamic cholinergic activity associated with 2-deoxyglucose-induced hyperglycemia. Brain Res, 1996, 734, 116-122.
23. Tomaszewicz M, Bielarczyk H, Jankowska A, Szutowicz A: Modification by nitric oxide acetyl-CoA and acetylcholine metabolism in nerve terminals. In: Neurochemistry, Cellular, Molecular and Clinical Aspects, AW Teelken, J Korf (eds). Plenum Publishing Co, New York, 1997a, pp 993-997.
24. Tomaszewicz M, Bielarczyk H, Jankowska A, Szutowicz A: Pathways of β-hydroxybutyrate contribution to metabolism of acetyl-CoA and acetylcholine in brain nerve terminals. Folia Neuropathol, 1997b, 35, in press.
25. Woźniak M, Rydzewski B, Baker SP, Raizada MK: The cellular and physiological action of insulin in the central nervous system. Neurochem Int, 1993, 22, 1-10.
26. Wurtman RJ: Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci, 1992, 15, 117-122.